Pharmaceutical Drug Delivery Market by Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, and Autoimmune Diseases), End-User, and Geography – Global Forecast up to 2026
- Report Code : IHR2185376
- Published On: Apr, 2021
- Category : Pharmaceuticals
- Pages : 110
-
Pharmaceutical drug delivery is referred to a device that is commonly used for the control or target drug delivery of a variety of therapeutic agents to treat several numbers of diseases or for better improvement in the health of the patients. Drug delivery systems are medical equipment utilized to infuse drugs or chemicals into the body and also used to stimulate drug absorption, efficiency, and experience of the patient. Rapidly increasing infectious and chronic diseases worldwide and growing research & developments in drug delivery are the major reasons responsible for the growth in the pharmaceutical drug delivery market. But somehow, the growth in incidences of drug recall and drug failures are limiting the market growth. The Pharmaceutical Drug Delivery Market is anticipated to grow at a CAGR of 4.6% during the forecast period of 2020-2026.
Research Methodology:
The pharmaceutical drug delivery market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:
Pharmaceutical Drug Delivery Market, by Route of Administration
• Oral Drug Delivery
• Pulmonary Drug Delivery
• Injectable Drug Delivery
• Ocular Drug Delivery
• Nasal Drug Delivery
• Topical Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery
Pharmaceutical Drug Delivery Market, by Application
• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases
Pharmaceutical Drug Delivery Market, by End User
• Hospitals
• Home Care Settings
• Ambulatory Survey Centers
• Diagnostic Centers
Pharmaceutical Drug Delivery Market, by Geography
• North America
• Europe
• Asia Pacific
• Rest of the World
If analyzed by the route of administration, the pharmaceutical drug delivery market is mainly dominated by the topical drug delivery segment. This segment has a major role in the market due to its benefits, such as satisfaction and ease of use, accurate dosage to a particular place, maximum absorption, no pain and non-intrusive delivery, and avoid fluctuation in drug delivery and majorly, best suitable for self-medication.
In the application market, pharmaceutical drug delivery is majorly applied in cancer diseases. The key reason is the increasing incidence of cancer all over the world and the increasing need for the latest and advanced therapeutics for cancer treatment, which is giving the majority for this segment in the application.
As per the end-user, the pharmaceutical drug delivery market is majorly divided into hospitals, home care settings, ambulatory survey centers, and diagnostic centers. The huge number of inpatient and outpatient visits to hospitals and the necessity of a huge amount of drugs and the respective delivery devices to render service to a large number of patients in the hospital are the reasons responsible for the largest share of hospitals in this market.
Geographically, the pharmaceutical drug delivery market is majorly segregated into North America, Europe, Asia Pacific, and the Rest of the World. North America is happening to hold a significant share in the market due to the encouraging government initiatives for the development of drug delivery technologies, increasing pharmaceutical investment with the rising cases of cancer, and emerging advanced technology in oral drug delivery in this region.
Some other aspects which are enhancing the pharmaceutical drug delivery market growth globally are rapidly increasing numbers of infectious and chronic diseases. This may result in growth in the biologics market, which is significantly stimulating global market growth. However, the risk involved in injectable drug delivery, such as needle stick injury, is hampering the market growth.
Some of the companies’ profiles are provided in the Pharmaceutical Drug Delivery Market-F. Hoffman-La Roche, Bayer AG, Pfizer, GlaxoSmithKline plc, Inc., Novartis AG, 3M Company, Becton, Dickinson and Company, Sanofi, Merck & Co., Inc., Antares Pharma, Inc., AbbVie, Amgen, Johnson & Johnson, Inc, AstraZeneca, Eli Lilly and Company, Gilead Sciences, Inc., Teva Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, and Genmab A/S.
Thus, advanced developments in pharmaceutical drug delivery, such as utilization to serve through diagnostic tools, are supporting the market growth further. This report provides the emerging developments in the drug delivery industry.
• This report of the pharmaceutical drug delivery market discusses the present state, innovations, and future needs of the market end-users.
• This study examines the various categories of drug delivery, divided by market shares of the key manufacturers and acquisitions, mergers, and alliances by vendors and global organizations.
• This research further analyses the stringent environment and the involved technology, including the new trends and developments.
• The pharmaceutical drug delivery market also presents the major vendors of the industry.
-
With tables and figures helping analyze worldwide Pharmaceutical Drug Delivery market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. PEST Analysis
3.2.2. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. Route of Administration: Market Size & Analysis
5.1. Overview
5.2. Oral Drug Delivery
5.3. Pulmonary Drug Delivery
5.4. Injectable Drug Delivery
5.5. Ocular Drug Delivery
5.6. Nasal Drug Delivery
5.7. Topical Drug Delivery
5.8. Implantable Drug Delivery
5.9. Transmucosal Drug Delivery
6. Application: Market Size & Analysis
6.1. Overview
6.2. Infectious Diseases
6.3. Cancer
6.4. Cardiovascular Diseases
6.5. Diabetes
6.6. Respiratory Diseases
6.7. Central Nervous System Disorders
6.8. Autoimmune Diseases
7. End-User: Market Size & Analysis
7.1. Overview
7.2. Home Care Settings
7.3. Ambulatory Survey Centers
7.4. Diagnostic Centers
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. F. Hoffman-La Roche
10.1.1. Overview
10.1.2. Financials
10.1.3. Products & Services
10.1.4. Recent Developments
10.1.5. Business Strategy
10.2. Bayer AG
10.2.1. Overview
10.2.2. Financials
10.2.3. Products & Services
10.2.4. Recent Developments
10.2.5. Business Strategy
10.3. Pfizer
10.3.1. Overview
10.3.2. Financials
10.3.3. Products & Services
10.3.4. Recent Developments
10.3.5. Business Strategy
10.4. GlaxoSmithKline plc, Inc
10.4.1. Overview
10.4.2. Financials
10.4.3. Products & Services
10.4.4. Recent Developments
10.4.5. Business Strategy
10.5. Novartis AG
10.5.1. Overview
10.5.2. Financials
10.5.3. Products & Services
10.5.4. Recent Developments
10.5.5. Business Strategy
10.6. 3M Company
10.6.1. Overview
10.6.2. Financials
10.6.3. Products & Services
10.6.4. Recent Developments
10.6.5. Business Strategy
10.7. Becton, Dickinson and Company
10.7.1. Overview
10.7.2. Financials
10.7.3. Products & Services
10.7.4. Recent Developments
10.7.5. Business Strategy
10.8. Sanofi
10.8.1. Overview
10.8.2. Financials
10.8.3. Products & Services
10.8.4. Recent Developments
10.8.5. Business Strategy
10.9. Merck & Co., Inc
10.9.1. Overview
10.9.2. Financials
10.9.3. Products & Services
10.9.4. Recent Developments
10.9.5. Business Strategy
10.10. Antares Pharma, Inc
10.10.1. Overview
10.10.2. Financials
10.10.3. Products & Services
10.10.4. Recent Developments
10.10.5. Business Strategy
11. Companies to Watch
11.1. AbbVie
11.1.1. Overview
11.1.2. Products & Services
11.1.3. Business Strategy
11.2. Amgen
11.2.1. Overview
11.2.2. Products & Services
11.2.3. Business Strategy
11.3. Johnson & Johnson, Inc
11.3.1. Overview
11.3.2. Products & Services
11.3.3. Business Strategy
11.4. AstraZeneca
11.4.1. Overview
11.4.2. Products & Services
11.4.3. Business Strategy
11.5. Eli Lilly and Company
11.5.1. Overview
11.5.2. Products & Services
11.5.3. Business Strategy
11.6. Gilead Sciences, Inc
11.6.1. Overview
11.6.2. Products & Services
11.6.3. Business Strategy
11.7. Teva Pharmaceuticals
11.7.1. Overview
11.7.2. Products & Services
11.7.3. Business Strategy
11.8. Boehringer Ingelheim
11.8.1. Overview
11.8.2. Products & Services
11.8.3. Business Strategy
11.9. Bristol-Myers Squibb
11.9.1. Overview
11.9.2. Products & Services
11.9.3. Business Strategy
11.10. Genmab A/S
11.10.1. Overview
11.10.2. Products & Services
11.10.3. Business Strategy
12. Analyst Opinion
13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
-
The Pharmaceutical Drug Delivery Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
It is expected that the Pharmaceutical Drug Delivery Market will reach USD XX million by 2029.
Yes, the add-on segmentation is available in the premium customised version of the Pharmaceutical Drug Delivery Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
Companies in the Pharmaceutical Drug Delivery Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Pharmaceutical Drug Delivery Market's trajectory and future outlook.
